Publicacions (25) Publicacions de BEATRIZ MERINO ANTOLIN

2024

  1. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

2023

  1. Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice

    Diabetes, Obesity and Metabolism, Vol. 25, Núm. 11, pp. 3268-3278

2022

  1. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

  2. Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme

    Frontiers in Endocrinology, Vol. 13

2021

  1. Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice

    Cells, Vol. 10, Núm. 9

  2. Fisiología del sistema endocrino: manual del estudiante

    Ediciones Universidad de Valladolid (EdUVa)

  3. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

  4. Sexual hormones and diabetes: The impact of estradiol in pancreatic β cell

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 81-138

  5. Targeting insulin-degrading enzyme in insulin clearance

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-21

2020

  1. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

    Metabolism: Clinical and Experimental, Vol. 113

  2. Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor

    Endocrine, Vol. 68, Núm. 3, pp. 557-563

  3. Intestinal fructose and glucose metabolism in health and disease

    Nutrients, Vol. 12, Núm. 1

2019

  1. Cortistatin regulates glucose-induced electrical activity and insulin secretion in mouse pancreatic beta-cells

    Molecular and Cellular Endocrinology, Vol. 479, pp. 123-132

  2. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity

    American journal of physiology. Endocrinology and metabolism, Vol. 317, Núm. 5, pp. E805-E819

2018

  1. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice

    Metabolism: Clinical and Experimental, Vol. 88, pp. 1-11

2016

  1. Maternal exposure to bisphenol-A during pregnancy increases pancreatic β-cell growth during early life in male mice offspring

    Endocrinology, Vol. 157, Núm. 11, pp. 4158-4171

  2. The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells

    Metabolism: Clinical and Experimental, Vol. 65, Núm. 3, pp. 54-63

2015

  1. Glucagon increases beating rate but not contractility in rat right atrium. comparison with isoproterenol

    PLoS ONE, Vol. 10, Núm. 7

  2. Pancreatic alpha-cells from female mice undergo morphofunctional changes during compensatory adaptations of the endocrine pancreas to diet-induced obesity

    Scientific Reports, Vol. 5

  3. Pancreatic α Cells are Resistant to Metabolic Stress-induced Apoptosis in Type 2 Diabetes

    EBioMedicine, Vol. 2, Núm. 5, pp. 378-385